BioSpace News Archive

Genetown

LabMinds Revo ® Wins the 2020 Edison Award

LabMinds, the leader in Robotics and AI for solution preparation in Life Sciences, announced that their innovative Revo ® automation system has been named a winner in the prestigious 2020 Edison Awards.

May 6, 2020
·
2 min read
BioCapital

Donna Brazile and Michael Steele Are Announced as Policy Keynote Speakers at the National Association of Specialty Pharmacy 2020 Annual Meeting & Expo

The National Association of Specialty Pharmacy has announced that former interim chair of the Democratic National Committee Donna Brazile and former chairman of the Republican National Committee Michael Steele will give a joint keynote presentation on the political landscape, election 2020 and the future of their respective parties.

May 6, 2020
·
3 min read
Medtronic Expands Diabetes Support Programs to Help Customers Losing Insurance Coverage Due to Job Loss as a Result of COVID-19

Medtronic Assurance Program Will Provide Access to Glucose Sensors and Insulin Pump Supplies at No Cost to Eligible U.S. Customers

May 6, 2020
·
3 min read
Biotech Beach

GNEM Symposium Speaker Series to Go Virtual

The Neuromuscular Disease Foundation (NDF) will launch its annual Symposium on GNE Myopathy Speaker Series on Friday, May 8th, albeit in a much different format than in previous years.

May 6, 2020
·
3 min read
Business

HealthyVerify is First-Ever Research-based Certification for Business Operations Post COVID-19

Customizable certification to restore public confidence; trust in protective measures launches nationwide

May 6, 2020
·
3 min read
Business

AIkido Pharma Executes Artificial Intelligence and Machine Learning Research Agreement with Cogia Biotech LTD

AIkido Pharma Inc. (Nasdaq: AIKI) today announced execution of an Artificial Intelligence (AI), and Machine Learning (ML) research agreement with Cogia Biotech LTD (“Cogia”) (www.cogia.de) to accelerate the Company’s pancreatic cancer genetic marker research.

May 6, 2020
·
4 min read
Biotech Bay

LakePharma Supplying Mount Sinai with SARS-CoV-2 Proteins for Serological Assays

LakePharma announces that the company will be supplying the Mount Sinai Health System recombinant SARS-CoV-2 spike proteins to the Mount Sinai Laboratory as a component in its blood test for antibody response against SARS-CoV-2, the virus that causes the COVID-19 pandemic.

May 6, 2020
·
3 min read
FDA

Novartis announces FDA approval of MET inhibitor Tabrecta™ for metastatic non-small cell lung cancer with METex14

Tabrecta (capmatinib, formerly INC280) is the first and only therapy approved by the FDA to specifically target metastatic NSCLC with a mutation that leads to MET exon 14 skipping (METex14)(1)

May 6, 2020
·
14 min read
FDA

Foundation Medicine Receives FDA Approval for FoundationOne®CDx as the Companion Diagnostic for Tabrecta™ (capmatinib), the Only FDA-Approved MET Inhibitor for Patients With Metastatic Non-Small Cell Lung Cancer With METex14

Foundation Medicine, Inc. announced that FoundationOne®CDx has been approved by the U.S. Food and Drug Administration for use as the companion diagnostic to aid in identifying patients with non-small cell lung cancer for whom treatment with Tabrecta™ may be appropriate.

May 6, 2020
·
4 min read
Deals

LifeSci Acquisition Corp. Announces that Common Stock and Warrants Commenced Separate Trading

LifeSci Acquisition Corp. announced that holders of the Company’s units may elect to separately trade the ordinary shares and warrants included in its units.

May 6, 2020
·
1 min read